The Emerging Role of Ferroptosis in Cardiovascular Diseases

Min Hong1, Jiabing Rong2, Xinran Tao2

  • 1School of Medicine, Zhejiang University, Hangzhou, China.

Frontiers in Pharmacology
|February 14, 2022
PubMed

Insights

Ferroptosis, an iron-dependent cell death, is crucial in cardiovascular diseases, unlike previously assumed apoptosis. Understanding ferroptosis mechanisms offers new therapeutic targets for heart conditions.

Area of Science:

  • Biomedical Science
  • Cellular Biology
  • Pathophysiology

Background:

  • Ferroptosis is a recently identified programmed cell death characterized by iron-dependent lipid peroxidation.
  • It differs morphologically, biochemically, and genetically from apoptosis, necroptosis, and autophagy.
  • Cardiovascular diseases are a leading global cause of death, with cardiomyocyte apoptosis traditionally considered the primary cell death mechanism.

Purpose of the Study:

  • To review the mechanisms of ferroptosis.
  • To elucidate the role of ferroptosis in the occurrence and development of cardiovascular diseases.
  • To identify ferroptosis as a potential therapeutic target for cardiovascular diseases.

Main Methods:

  • Literature review of ferroptosis mechanisms.
  • Analysis of ferroptosis's role in cardiovascular disease pathogenesis.
  • Discussion of therapeutic implications.

Main Results:

  • Ferroptosis, distinct from apoptosis, significantly contributes to cardiovascular diseases.
  • Iron, lipid, and antioxidant metabolism are key players in ferroptosis.
  • Emerging evidence highlights ferroptosis's critical role in cardiomyocyte death.

Conclusions:

  • Ferroptosis is a major contributor to cardiovascular diseases, challenging the traditional view of apoptosis as the sole mechanism.
  • Targeting ferroptosis pathways presents a novel therapeutic strategy for cardiovascular disease prevention and treatment.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.9K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
72
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
841
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
2.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
78
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
90